Publications by authors named "Jose Maria Roca"

Claim this Profile
A
Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.
Miguel Nogué, Antonieta Salud, Pilar Vicente, Antonio Arriví, José María Roca

Oncologist· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer.
José-María Roca, Vicente Alonso, Carles Pericay, Pilar Escudero, Antonieta Salud

Chemotherapy· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis